Ignite Creation Date:
2025-12-25 @ 4:22 AM
Ignite Modification Date:
2026-05-20 @ 2:50 AM
Study NCT ID:
NCT06275620
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-10-30
First Post:
2024-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
Sponsor:
Beacon Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | X-Linked Retinitis Pigmentosa | View |